A drug used to help patients lose weight and manage diabetes may also help those with heart failure , an international clinical trial shows. The test of tirzepatide , brand named Zepbound, included 731 patients with diastolic heart failure and obesity who were followed for two years. Advertisement "This class of drugs continue to show benefits far beyond weight loss," said researcher Dr. Christopher Kramer , chief of cardiovascular medicine at UVA Health. "This drug will become an important